SCHEMBL24988682

SCHEMBL24988682

CCCCCCc1cc(N)c2[nH]c(-c3ccc(SF)cc3)cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPL P40238 3/20 0.39
GPR84 Q9NQS5 3/20 0.39
CTSV O60911 2/20 0.38
CTSL P07711 2/20 0.38
S1PR4 O95977 3/20 0.34
S1PR1 P21453 3/20 0.34
S1PR5 Q9H228 3/20 0.34
MAPT P10636 2/20 0.34
RAB9A P51151 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
S1PR3 Q99500 1/20 0.32
TLR8 Q9NR97 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24990242 0.84 CTSV (0.44) MPLGPR84CTSVCTSLHTR2A
SCHEMBL24989606 0.83 ADK (0.40) MPLGPR84CTSVCTSLS1PR4
SCHEMBL24988674 0.74 MPL (0.41) MPLGPR84CTSVCTSLMAPT
SCHEMBL24989509 0.74 NPY5R (0.43) MAPTRAB9AKDM4EMEN1ALDH1A1
SCHEMBL29185311 0.71 NPY5R (0.38) S1PR4S1PR1S1PR5MAPTRAB9A
SCHEMBL30848950 0.71 NPY5R (0.38) S1PR4S1PR1S1PR5MAPTRAB9A
SCHEMBL24988657 0.69 CTSV (0.43) MPLGPR84CTSVCTSLRAB9A
SCHEMBL30182908 0.69 NPY5R (0.39) MAPTRAB9AKDM4EMEN1KMT2A
SCHEMBL24989505 0.67 TLR8 (0.42) MPLCTSVCTSLTLR8
SCHEMBL24988641 0.67 TLR8 (0.42) MPLCTSVCTSLTLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023013994-A1 NOVEL INDOLE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 주식회사 미토이뮨테라퓨틱스 2023-02-09 WO disclosed